Cas:108831-68-1 4-Chloro-5,6-dimethylthieno[2,3-d]pyrimidine manufacturer & supplier

We serve Chemical Name:4-Chloro-5,6-dimethylthieno[2,3-d]pyrimidine CAS:108831-68-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Chloro-5,6-dimethylthieno[2,3-d]pyrimidine

Chemical Name:4-Chloro-5,6-dimethylthieno[2,3-d]pyrimidine
CAS.NO:108831-68-1
Synonyms:MFCD00464832;4-chloro-5,6-dimethylthieno[2,3-d]pyrimidine
Molecular Formula:C8H7ClN2S
Molecular Weight:198.67300
HS Code:2934999090

Physical and Chemical Properties:
Melting point:112ºC
Boiling point:322.8ºC at 760mmHg
Density:1.379g/cm3
Index of Refraction:1.66
PSA:54.02000
Exact Mass:198.00200
LogP:2.96150

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00464832 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-5,6-dimethylthieno[2,3-d]pyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00464832 Use and application,4-chloro-5,6-dimethylthieno[2,3-d]pyrimidine technical grade,usp/ep/jp grade.


Related News: The Company intends to further develop candidates from Mindset Families 2-4 with the goal of selecting additional lead candidates in the near future. methyl (2-((S)-2-(2-(((benzyloxy)carbonyl)amino)-2-methylpropanamido)propanamido)-2-methylpropanoyl)-L-alaninate manufacturers The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. (1R,5S)-3-(3,4,5-trimethoxybenzoyl)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. L-Leucine, L-leucyl-L-leucyl-L-arginyl-L-prolyl-L-isoleucyl- vendor & factory.